Patents
Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
02/2008
02/14/2008US20080039327 3-heterocyclyl-substituted benzoyl derivatives
02/13/2008EP1885817A1 Responsive luminescent lanthanide complexes
02/13/2008EP1432677B1 Novel urea oligomers, the preparation method thereof and pharmaceutical compositions containing same
02/13/2008CN101124212A Chroman derivatives and their use as 5-HT receptor ligands
02/13/2008CN101121707A Method for preparing 3,4-dihydro-4-oxy-2H-1-benzopyran-2-carboxylic acids compounds
02/13/2008CN101121706A Coumarin derivatives, preparation method and use thereof
02/13/2008CN101121705A Technique for preparing tea polyphenols
02/13/2008CN100368408C Method of extracting licorice flavone from licorice slag
02/12/2008US7329687 Anticancer agents; antiproliferative agents
02/07/2008WO2008014722A1 Prenyl flavonoids,their preparation and use
02/07/2008US20080032995 Aldh-2 inhibitors in the treatment of drug addiction
02/07/2008US20080032982 2-{2-[3-(4-chlorophenyl)acryloyl]-4-methylphenoxy}-4-phenylbutanoic acid; Peroxisome Proliferator Activated Receptors (PPAR); diabetes, dyslipidemia and/or atherosclerosis
02/06/2008CN101119989A Chroman derivatives and uses thereof
02/06/2008CN100366630C Preparation of suaveolic flavone for treating chronic pharyngitis and chronic tonsilltiis
02/06/2008CN100366628C Effective parts of fructus sophorae flavone production and use thereof
02/06/2008CN100366605C Compounds to treat alzheimer's disease
02/05/2008US7326797 Manufacture of isoflavones
02/05/2008US7326447 Benzochromene derivatives
01/2008
01/31/2008WO2008014497A2 Aldh-2 inhibitors in the treatment of addiction
01/31/2008WO2008011964A1 New materials for organic electroluminescent devices
01/31/2008WO2007123941A3 Chromane and chromene derivatives and uses thereof
01/31/2008US20080027228 Substituted thioacetamides
01/31/2008US20080027133 Use of chromen-4-one derivatives
01/31/2008US20080027132 1,1,1,3,3,3-hexachloro-2-methylpropan-2-yl 4-((4-hydroxy-2-oxo-2H-chromen-3-yl)methyl)benzoate; side effect reduction over warfarin
01/31/2008US20080027112 enzyme inhibitors of phosphodiesterase 4; antiinflammatory agent for the treatment or prevention of inflammatory diseases and other diseases involving elevated levels of cytokines
01/31/2008US20080026407 Covalent tethering of functional groups to proteins
01/31/2008US20080026087 Litchi Sinensis Extracts Containing Oligomeric Proanthocyanidins and Processes of Making Thereof
01/31/2008US20080023646 Photostabilisation of Fluorescent Dyes
01/31/2008CA2653056A1 Aldh-2 inhibitors in the treatment of addiction
01/30/2008CN101115734A Spiro derivatives as lipoxygenase inhibitors
01/30/2008CN101115719A Substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives
01/30/2008CN101113147A Method for tea by-product resource utilization
01/30/2008CN101113146A Process for the separation of blood fat recovery purpose-made monascus active ingredient
01/30/2008CN100364985C Method of preparing tea polyphenol by resin adsorption method
01/29/2008US7323596 Antibacterial or antiprotozoal activity: formula (1) formula (2) wherein: Z represents a radical of formula N(OH)CH( .dbd. O) or of formula C( .dbd. O)NH(OH); R1 represents hydrogen, methyl or trifluoromethyl, or, except when Z is a radical of
01/29/2008US7323587 Selective estrogen receptor modulators
01/29/2008US7323576 Synthetic route to dronabinol
01/29/2008US7323195 Enteric formulations of proanthocyanidin polymer antidiarrheal compositions
01/24/2008WO2008011364A2 Quercetin-containing compositions
01/24/2008WO2008011363A2 Quercetin-containing compositions
01/24/2008WO2008010403A1 Method for preventing coloration of catechins and dentifrice composition
01/24/2008WO2008009934A1 Synthesis of 2-amino-substituted 4-oxo-4h-chromen-8.yl-trifluoro-methanesulfonic acid esters
01/24/2008WO2008009741A1 Novel chromene and thiochromene carboxamide derivatives, methods for preparing same and therapeutic applications of same
01/24/2008WO2008009435A1 Amino-piperidine derivatives as cetp inhibitors
01/24/2008WO2007091697A3 Method for preparing prostaglandin derivative
01/24/2008US20080021227 Antineoplastic cocoa extracts and methods for making and using the same
01/24/2008US20080021095 Small Molecule Antagonists of Xiap Family Proteins
01/24/2008US20080020237 Light emitting device containing phosphorescent complex
01/24/2008US20080020148 Chromane Derivatives Method for Production and the Use Thereof
01/24/2008US20080020068 Use Of Trisubstituted Benzopyranones
01/24/2008CA2659524A1 Novel chromene and thiochromene carboxamide derivatives, methods for preparing same and therapeutic applications of same
01/24/2008CA2657258A1 Amino-piperidine derivatives as cetp inhibitors
01/23/2008EP1880995A1 Method for producing indole derivative having piperidine ring
01/23/2008EP1879847A1 Terrylene and quaterrylene derivatives
01/23/2008EP1711825A4 Conjugated small molecules
01/23/2008EP1567498B1 Mandelic acid derivatives
01/23/2008EP1311261B1 Medicaments for chemotherapeutic treatment of disease
01/23/2008CN101111482A Luminescent indicator dye and optical sensor
01/23/2008CN101108842A Process technique for extracting tea polyphenol from tree plant flower
01/23/2008CN100363378C Method for producing mixture of phytosterol and vitamin E
01/23/2008CN100363366C Camptothecin derviative and preparation process thereof
01/23/2008CN100363358C Process for producing aminobenzopyran compound
01/23/2008CN100363357C Manufacture of isoflavones
01/23/2008CN100363356C Benzopyrone compounds and its preparation and use
01/22/2008US7321053 Esterifying tocol or a tocopherol in the presence of solid heterogeneous inorganic Bronsted acid catalyst (H2SO4, H3PO4) on a carrier of both SiO2 and TiO2 with a BET surface area of 10 to 800 m2/g and a pore volume of 0.1 to 2.0 ml/g.; preparing (all-rac)-alpha -tocopheryl acetate.
01/22/2008US7321047 Separation of tetrahydrocannabinols
01/22/2008US7320826 comprises 3-(4-methoxyphenyl)-3-phenyl-6,7,10,11-tetramethoxy-13-ethyl-13-hydroxy-13H-3H-indeno[2,'3,'3,4]naphtho[1,2-b]pyran; for activation via actinic radiation; improved optical density response; ophthalmic lens
01/17/2008WO2008007780A1 Pentadienamide derivative
01/17/2008WO2008006836A1 Process for the preparation of chromene, thiochromene and dihydroquinoline derivatives from 2-hydroxy-, 2-mercapto- and 2-aminobenzaldehydes
01/17/2008WO2008006454A1 Electroluminescent polymers and use thereof
01/17/2008US20080015367 Process for isolating phytosterols and tocopherols from deodorizer distillate
01/17/2008US20080015354 Novel Process For The Preparation Of 2H-Chromenes
01/17/2008US20080015248 synthetic tea derived flavonoids, used for the of treatment of cancers; anticarcinogenic agents; enzyme inhibitors
01/17/2008US20080015247 quercetin, vitamin B3, and vitamin C as only ingredients, specified weight ratio; dietary supplement or a pharmaceutical formulation; free radical induced diseases
01/17/2008US20080015232 Schweinfurthin analogues
01/17/2008US20080014249 Compositions and therapeutic methods involving isoflavones and analogues thereof
01/17/2008US20080014147 Tumor specific fluorescent dye
01/17/2008US20080011985 Substituted Cumarines, Process for the Production of Said Cumarines and Composition Containing Said Cumarines
01/17/2008CA2658097A1 Pentadienamide derivatives
01/16/2008EP1877856A1 Photochromic blue light filtering materials and ophthalmic devices
01/16/2008EP1877097A2 Aminoacid conjugates of beta-lapachone for tumor targeting
01/16/2008EP1622889A4 Pesticidal (dihalopropenyl)phenylalkyl substituted benzodioxolane and benzodioxole derivatives
01/16/2008CN101106987A Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same
01/16/2008CN101104612A Flavonol beta-secretase inhibitor in ginkgo leaf standard extract, extracting method and use thereof
01/16/2008CN101104611A 3-methoxylflavonoid compound, preparation method and application thereof
01/16/2008CN101104598A Process for preparing trans-4-amino-1-cyclohexanecarboxilic acid derivatives
01/16/2008CN100361988C Separation of licoflavone from liquorice by solvent extraction method
01/15/2008US7318991 Diphenylsulfonium compounds in which the S atom is additionally attached to a xanthene-9-onyl-2-yl- or coumarin-7-yl- ring; acid generator for a chemically amplified resist; photopolymerization initiator for polymerizing an epoxide or a vinyl ether
01/15/2008US7318966 Luminescent element material and luminescent element comprising the same
01/15/2008US7318940 Grinding seeds to fine powder without precooling; defatting in hydrocarbon solvent (hexane or petroleum ether); extraction with medium polarity solvent (acetone) at 18 to 56 degrees C; evaporation of solvent; drying; and washing and drying crystalline silymarin extract.
01/10/2008WO2008005954A2 Tryphostin-analogs for the treatment of cell proliferative diseases
01/10/2008WO2008005414A2 Acetals of nepetalic acid and method of preparation
01/10/2008WO2008004774A1 Manufacturing method of gallocatechin gallate by epimerization of epigallocatechin-3-gallate
01/10/2008WO2008003774A1 Method for producing enantiopure flavanones
01/10/2008US20080009504 enzyme inhibitors of glucan synthase;1S,2R,3R,4aR,6aS,7R,8R,10aR,10bR,12aR)-3-(acetyloxy)-2-[(2S)-2-amino-2,3-dimethylbutyloxy]-8-[(1R)-1,2-dimethyl propyl]-1,6a,8,10a-tetramethyl-6-oxo-1,3,4,6,6a,7,8,9,10,10a,10b,11,12,12a-tetradecahydro-2H-1,4a-(methanooxymethano)chrysene-7-carboxylic acid
01/10/2008US20080009450 Genipin derivatives and uses thereof
01/10/2008US20080008965 Ester compounds and their preparation, polymers, resist compositions and patterning process
01/10/2008US20080008773 Food beverage or feed for the promotion of osteogenesis comprising umbelliferae, liliaceae or compositae plant species
01/10/2008US20080006798 chromenes, spiroindoline naphthoxazines linked to polysiloxanes; living polymerization; reduced fade half life; optical lenses, face shields, goggles, visors, camera lenses, windows, automotive windshields, aircraft and automotive transparencies, plastic films and sheets
01/10/2008DE102006032499A1 Preparing (2S)- or (2R)- flavones comprises reducing a racemic mixture of the flavones with formic acid and a base in the presence of a chiral imidazolidine catalyst and a chiral diamine ligand, and removing the unreacted enantiomers
1 ... 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 ... 242